Share Twitter LinkedIn Facebook Email Yasir Khan, MD, UC Irvine Health, compares Low Molecular Weight Heparin vs. DOACS in the management of DVT and VTE at the MOASC Spotlight on ASH 2017. Advertisement
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read